Latest FluoGuide News & Updates

See the latest news and media coverage for FluoGuide. We track all announcements, press releases, and industry mentions in real time, all in one place.

FluoGuide

Clinical-stage biotechnology company developing precision cancer surgery drugs

fluoguide.com

Headquarters: Copenhagen, Denmark
Founded year: 2018
Company type: Private company
Number of employees: 10–15
Industry: Biotechnology & Medical Research

Last updated October 5

Latest news about FluoGuide

In short: FluoGuide enrolled first U.S. Phase 2 patient for FG001 after FDA clearance.

Company announcements

August 25 FluoGuide

FluoGuide releases its Q2 2026 financial and clinical results

The firm highlights Phase 2 trial progress for FG001 in oncology while sharing quarterly earnings and balance sheet metrics.

June 29 FluoGuide

FluoGuide reports positive Phase 2 oral cancer trial results

Optimal dose 0.30 mg/kg identified in 15 patients; FG001 well tolerated and detected by all near-infrared imaging systems.

May 27 FluoGuide

FluoGuide publishes interim report for Q1 2026

The report details FDA IND authorization and Fast Track Designation for FG001, and progress in head and neck cancer program.

April 13 FluoGuide

FluoGuide presents positive interim FG001 study results

Dr. Jane Skjøth-Rasmussen shared data at Brain Tumor Symposium 2026 in Copenhagen, highlighting FG001's potential to improve tumor delineation in meningioma and low-grade glioma surgery.

Media coverage

October 5 BioSpace

FluoGuide Enrolls First Patient in U.S. Phase 2 Trial of FG001 in High-Grade Glioma - BioSpace

KØBENHAVN, DK / ACCESS Newswire / October 5, 2026 / FluoGuide A/S (STO:FLUO) - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotechnology company focused...

October 2 BioSpace

FluoGuide Enters Collaboration with Leica Microsystems, a World Leading Medical Technology Company

"We're pleased to join forces with Leica, a world leader in medical technology, to advance precision surgery for brain tumors. Combining FG001 with Leica's microscope...

August 25 Investing.com

Earnings Call Transcript: FluoGuide advances US cancer study in the first half of 2026

FluoGuide reported progress on its imaging-based cancer diagnostics platform for the first half of 2026. Key milestones included FDA approval for the first US study site for...

August 24 Zone Bourse

FluoGuide A/S publishes its results for the second quarter and the first half year ended June 30, 2026

FluoGuide A/S has published its financial results for the second quarter and the first half year ended June 30, 2026. For the second quarter, the...

Never miss news about FluoGuide

Track FluoGuide and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.